A role for B cells in resistance to Cryptococcus neoformans in mice

Infection and Immunity

Volumn 65, Issue 2, 1997, Pages 525-530

  Aguirre, Karen M ^a   Johnson, Lawrence L ^a  

^a TRUDEAU INSTITUTE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CRYPTOCOCCOSIS; CRYPTOCOCCUS NEOFORMANS; HOST RESISTANCE; HUMORAL IMMUNITY; INFECTION RESISTANCE; NONHUMAN; PRIORITY JOURNAL; SCID MOUSE; T LYMPHOCYTE SUBPOPULATION; VACCINATION;

EID: 0031020232     PISSN: 00199567     EISSN: None     Source Type: Journal    
DOI: 10.1128/iai.65.2.525-530.1997     Document Type: Article

References (35)

1. Aguirre, K., E. A. Havell, G. W. Gibson, and L. L. Johnson. 1995. Role of tumor necrosis factor and gamma interferon in acquired resistance to Cryptococcus neoformans in the central nervous system of mice. Infect. Immun. 63:1725-1731.
2. Aguirre, K. M., P. C. Sayles, G. W. Gibson, and L. L. Johnson. 1996. Resistance to Cryptococcus neoformans is associated with an inflammatory response to Toxoplasma gondii in the central nervous system of mice. Infect. Immun. 64:77-82.
3. Armitage, R. J., T. W. Tough, B. M. Macduff, W. C. Fanslow, M. K. Spriggs, F. Ramdell, and M. R. Alderson. 1993. CD40 ligand is a T cell growth factor. Eur. J. Immunol. 23:2326-2331.
4. Asano, M. S., and R. Ahmed. 1996. CD8 T cell memory in B cell-deficient mice. J. Exp. Med. 183:2165-2174.
5. Casadevall, A. 1995. Antibody immunity and invasive fungal infections. Infect. Immun. 63:4211-4218.
6. + T lymphocytes. J. Immunol. 152:1523-1531.
7. Dromer, F., J. Charreire, A. Contrepois, C. Carbon, and P. Yeni. 1987. Protection of mice against experimental cryptococcosis by anti-Cryptococcus neoformans monoclonal antibody. Infect. Immun. 55:749-752.
8. Epstein, M. M., F. DiRosa, D. Jankovic, A. Sher, and P. Matzinger. 1995. Successful T cell priming in B cell-deficient mice. J. Exp. Mod. 182:915-922.
9. Gadebusch, H. H. 1981. Passive immunization against Cryptococcus neoformans. Proc. Soc. Exp. Biol. 98:611-614.
10. Graybill, J. R., M. Hague, and D. J. Drutz. 1981. Passive immunization in murine cryptococcosis. Sabouraudia 19:237-244.
11. Hilbert, D. M., A. O. Anderson, K. L. Holmes, and S. Rudikoff. 1994. Long-term lymphoid reconstitution of SCID mice suggests self-renewing B and T cell populations in peripheral and mucosal tissue. Transplantation 58:466-475.
12. + T cells. J. Exp. Med. 173:755-758.
13. + T cell-dependent acquired state of immunity that protects the brain against Cryptococcus neoformans. J. Immunol. 152:2344-2350.
14. + T cells. J. Exp. Med. 175:793-748.
15. Iseki, M., M. Anzo, N. Yamashita, and N. Matsuo. 1994. HypEr-IgM immunodeficiency with disseminated cryptococcosis. Acta Paediatr. 83:780-782.
16. Johnson, L. L. Unpublished data.
17. Kitamura, D., J. Roes, R. Kuhn, and K. Rajewsky. 1991. A B cell-deficient mouse by targeted disruption of a membrane exon of the immunoglobulin μ chain gene. Nature 350:423-426.
18. Kozel, T. R. 1443. Cryptococcosis, p. 277-302. In J. W. Murphy (ed.), Fungal infection and immune responses. Plenum Press, New York.
19. Liu, Y., Y. Wu, L. Ramarathinam, Y. Guo, D. Huszar, M. Trounstein, and M. Zhzo. 1445. Gene-targeted B-deficient mice reveal a critical role for B cells in the CD4 T cell response. Int. Immunol. 7:1353-1362.
20. Louria, D. B., and T. Kaminski. 1965. Passively-acquired immunity to experimental cryptococcosis. Sabouraudia 4:80-84.
21. + T cells in vivo decreases pulmonary clearance of a moderately virulent strain of Cryptococcus neoformans. J. Lab. Clin. Med. 121:765-764.
22. Monga, D. P., R. Kumar, L. N. Mohapatra, and A. N. Malaviya. 1979. Experimental cryptococcosis in normal and B-cell-deficient mice. Infect. Immun. 26:1-3.
23. Mukherjee, J., A. Casadevall, and M. D. Scharff. 1993. Molecular characterization of the antibody responses to Cryptococcus neoformans infection and glucuronoxylomannan-tetanus toxoid conjugate immunization. J. Exp. Med. 177:1105-1106.
24. Mukherjee, J., L. Zuckier, M. D. Scharff, and A. Casadevall. 1994. Therapeutic efficacy of monoclonal antibodies to Cryptococcus neoformans glucuronoxylomannan alone and in combination with amphotericin B. Antimicrob. Agents Chemother. 38:580-587.
25. Mukherjee, J., M. D. Scharff, and A. Casadevall. 1992. Protective murine monoclonal antibodies to Cryptococcus neoformans. Infect. Immun. 60:4534-4541.
26. Mukherjee, J., L. Pirotski, M. D. Scharff, and A. Casadevall. 1993. Antibody-mediated protection in mice with lethal intracerebral Cryptococcus neoformans infection. Proc. Natl. Acad. Sci. USA 90:3636-3640.
27. Murphy, J., and G. C. Cozad. 1972. Immunological unresponsiveness induced by cryptococcal polysaccharide assayed by the hemolytic plaque technique. Infect. Immun. 5:896-901.
28. Reimann, J., A. Rudolphi, and M. H. Claesson. 1991. Selective reconstitution of T lymphocyte subsets in SCID mice. Immunol. Rev. 124:75-95.
29. Sanford, J. E., D. M. Lupan, A. M. Schlageter, and T. R. Kozel. 1990. Passive immunization against Cryptococcus neoformans with an isotype-switch family of monoclonal antibodies reactive with cryptococcal polysaccharide. Infect. Immun. 58:1919-1923.
30. Sarosi, G. A., J. D. Parker, K. Doto, and F. E. Tosh. 1992. Amphotericin B in cryptococcal meningitis. Ann. Intern. Med. 71:1079-1087.
31. Sayles, P. C. Unpublished data.
32. Sprent, J., M. Schaefer, M. Hurd, C. D. Sarh, and Y. Ron. 1991. Mature murine B and T cells transferred to SCID mice can survive indefinitely and maintain a virgin phenotype. J. Exp. Med. 174:717-728.
33. Varma, A., J. C. Edman, and K. J. Kwon-Chung. 1992. Molecular and genetic analysis of URA5 transformants of Cryptococcus neoformans. Infect. Immun. 60:1101-1108.
34. Vella, A. T., M. T. Scherer, S. Shultz, J. W. Kappler, and P. Marrack. 1996. B cells are not essential for peripheral T-cell tolerance. Proc. Natl. Acad. Sci. USA 93:951-955.
35. Zhong, Z., and L.-A. Pirofski. 1996. Opsonization of Cryptococcus neoformans by human anticryptococcal glucuronoxylomannan antibodies. Infect. Immun. 64:3446-3450.